Rivaroxaban

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Rivaroxaban and local guidelines before prescribing.

Direct factor Xa inhibitor (DOAC)

Mechanism

Direct factor Xa inhibitor.

Uses

Stroke prevention in non-valvular AF, VTE treatment and prophylaxis, secondary prevention in coronary and peripheral artery disease.

Dosing

4 more dose entries from the chapters

Side effects

Bleeding, anaemia, nausea, abnormal LFT.

Interactions

Strong CYP3A4 and P-gp inhibitors or inducers; avoid other anticoagulants.

Contraindications and cautions

Active bleeding, mechanical valve, severe liver disease

Monitoring

Renal function, Hb

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Avoid if CrCl below 15

Overdose and reversal

Andexanet alfa or prothrombin complex concentrate

Special advice

Take with food for 15 and 20 mg doses; reduce or avoid in renal impairment; andexanet alfa reversal.

More from the textbook: uses, cautions and other points
Where it is discussed in the book